EXERNA Trademark

Trademark Overview

On Tuesday, April 7, 2015, a trademark application was filed for EXERNA with the United States Patent and Trademark Office. The USPTO has given the EXERNA trademark a serial number of 86589603. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, August 28, 2017. The EXERNA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, exosomes to deliver RNA (Ribonucleic acid) for genetic therapy
exerna

General Information

Serial Number86589603
Word MarkEXERNA
Filing DateTuesday, April 7, 2015
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, August 28, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, exosomes to deliver RNA (Ribonucleic acid) for genetic therapy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 15, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressDundas, ON L9H1W9
CA

Trademark Events

Event DateEvent Description
Monday, August 28, 2017ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, August 28, 2017ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, January 30, 2017NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, January 30, 2017INQUIRY TO SUSPENSION E-MAILED
Monday, January 30, 2017SUSPENSION INQUIRY WRITTEN
Thursday, July 28, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, July 28, 2016LETTER OF SUSPENSION E-MAILED
Thursday, July 28, 2016SUSPENSION LETTER WRITTEN
Friday, July 15, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 15, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 15, 2016ASSIGNED TO LIE
Monday, July 11, 2016TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, January 22, 2016NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, January 22, 2016INQUIRY TO SUSPENSION E-MAILED
Friday, January 22, 2016SUSPENSION INQUIRY WRITTEN
Wednesday, July 15, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, July 15, 2015LETTER OF SUSPENSION E-MAILED
Wednesday, July 15, 2015SUSPENSION LETTER WRITTEN
Wednesday, July 15, 2015EXAMINER'S AMENDMENT ENTERED
Wednesday, July 15, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, July 15, 2015EXAMINERS AMENDMENT E-MAILED
Wednesday, July 15, 2015EXAMINERS AMENDMENT -WRITTEN
Wednesday, July 15, 2015ASSIGNED TO EXAMINER
Wednesday, April 15, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM

Related Keywords

exerna acid genetic therapy ribonucleic deliver preparations namely exosomes pharmaceutical